Recent years have seen a dramatic increase in start-ups and investors developing psychedelic medicines. Simeon Schanpper is a founder and managing partner of JLS Fund, a venture capital fund investing in plant based and psychedelic medicines that aim to heal illness and enhance wellness. We talked about the tensions between philanthropic and for-profit investment, the challenges and opportunities of this explosive new sector, and his own fascinating personal journey which included running a medical marijuana dispensary and psychedelic art gallery in Venice Beach, California.

 Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

<p>Recent years have seen a dramatic increase in start-ups and investors developing psychedelic medicines. Simeon Schanpper is a founder and managing partner of JLS Fund, a venture capital fund investing in plant based and psychedelic medicines that aim to heal illness and enhance wellness. We talked about the tensions between philanthropic and for-profit investment, the challenges and opportunities of this explosive new sector, and his own fascinating personal journey which included running a medical marijuana dispensary and psychedelic art gallery in Venice Beach, California.</p><p> </p> Learn more about your ad-choices at <a href="https://www.iheartpodcastnetwork.com">https://www.iheartpodcastnetwork.com</a>

Drugs, drugs, drugs. Almost everyone uses them. Almost everyone has an opinion about them. Drug policy pioneer Ethan Nadelmann gets to the bottom of our strange relationship to drugs by talking with those who love them, hate them, and study them.
We’d love to hear your stories and ideas. Send us a note at psychoactive@protozoa.com or leave a voicemail at 1-833-PSYCHO-0 (1-833-779-2460).

PSYCHOACTIVE

Simeon Schnapper on Psychedelics and Venture Capital

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/830e7f0a-d5c7-4ca1-82f8-ae2f0057303e/transcript

Advertisement